| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |